Semaglutide (the active ingredient in GLP-1 medications) works by mimicking a hormone that regulates blood sugar levels and reduces appetite
[DOI: 10.1371/journal.pone.0028268 LK - [DOI] [PMC free article] [PubMed] [Google Scholar] 23.Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, DiR Karnad, Kleinpell RM, Koh Y, Lisboa TC, MacHado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van Der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP
Both studies are limited by small sample sizes, short follow-up periods, and unclear parallel controls in the latter
Vials simplify accurate dosage measurements, essential for precise and reliable clinical studies on peptide effects in both animals and humans
